Considering the crucial impact of tau kinases and tau phosphatases on the abnormal hyperphosphorylation of tau in the brains of patients with AD, we further examined the protein levels of tau kinases and tau phosphatases. This evidence concerns the gene MAPT and Alzheimer disease.